Literature DB >> 2364431

Recognition of a bacterial adhesion by an integrin: macrophage CR3 (alpha M beta 2, CD11b/CD18) binds filamentous hemagglutinin of Bordetella pertussis.

D Relman1, E Tuomanen, S Falkow, D T Golenbock, K Saukkonen, S D Wright.   

Abstract

During the course of whooping cough, Bordetella pertussis interacts with alveolar macrophages and other leukocytes on the respiratory epithelium. We report here mechanisms by which these bacteria adhere to human macrophages in vitro. Whole bacteria adhere by means of two proteins, filamentous hemagglutinin (FHA) and pertussis toxin, either of which is sufficient to mediate adherence. FHA interacts with two classes of molecules on macrophages, galactose-containing glycoconjugates and the integrin CR3 (alpha M beta 2, CD11b/CD18). The interaction between CR3 and FHA involves recognition of the Arg-Gly-Asp (RGD) sequence at positions 1097-1099 in FHA. This study demonstrates that bacterial adherence can be based on the interaction of a bacterial adhesin RGD sequence with an integrin and that bacterial adhesins can have multiple binding sites characteristic of eukaryotic extracellular matrix proteins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2364431     DOI: 10.1016/0092-8674(90)90701-f

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  143 in total

1.  Intracellular growth in Acanthamoeba castellanii affects monocyte entry mechanisms and enhances virulence of Legionella pneumophila.

Authors:  J D Cirillo; S L Cirillo; L Yan; L E Bermudez; S Falkow; L S Tompkins
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Role of Bordetella pertussis virulence factors in adherence to epithelial cell lines derived from the human respiratory tract.

Authors:  B M van den Berg; H Beekhuizen; R J Willems; F R Mooi; R van Furth
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

3.  Stereotyped and specific gene expression programs in human innate immune responses to bacteria.

Authors:  Jennifer C Boldrick; Ash A Alizadeh; Maximilian Diehn; Sandrine Dudoit; Chih Long Liu; Christopher E Belcher; David Botstein; Louis M Staudt; Patrick O Brown; David A Relman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

4.  Adherence of Burkholderia pseudomallei cells to cultured human epithelial cell lines is regulated by growth temperature.

Authors:  Nat F Brown; Justin A Boddey; Cameron P Flegg; Ifor R Beacham
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

5.  Role of carbohydrate recognition domains of pertussis toxin in adherence of Bordetella pertussis to human macrophages.

Authors:  J van't Wout; W N Burnette; V L Mar; E Rozdzinski; S D Wright; E I Tuomanen
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

6.  Uptake and intracellular survival of Bordetella pertussis in human macrophages.

Authors:  R L Friedman; K Nordensson; L Wilson; E T Akporiaye; D E Yocum
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

7.  The prodomain of the Bordetella two-partner secretion pathway protein FhaB remains intracellular yet affects the conformation of the mature C-terminal domain.

Authors:  Christopher R Noël; Joseph Mazar; Jeffrey A Melvin; Jessica A Sexton; Peggy A Cotter
Journal:  Mol Microbiol       Date:  2012-10-05       Impact factor: 3.501

Review 8.  Contact-Dependent Growth Inhibition (CDI) and CdiB/CdiA Two-Partner Secretion Proteins.

Authors:  Julia L E Willett; Zachary C Ruhe; Celia W Goulding; David A Low; Christopher S Hayes
Journal:  J Mol Biol       Date:  2015-09-24       Impact factor: 5.469

9.  Contribution of Bordetella bronchiseptica filamentous hemagglutinin and pertactin to respiratory disease in swine.

Authors:  Tracy L Nicholson; Susan L Brockmeier; Crystal L Loving
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

10.  Invasion and intracellular survival of Bordetella bronchiseptica in mouse dendritic cells.

Authors:  C A Guzman; M Rohde; M Bock; K N Timmis
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.